Qube Research & Technologies LTD Co Diagnostics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 13 shares of CODX stock, worth $16. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$16
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CODX
# of Institutions
50Shares Held
4.51MCall Options Held
3.3KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny587KShares$745,4900.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$637,5710.0% of portfolio
-
Geode Capital Management, LLC Boston, MA317KShares$403,0720.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$346,5830.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $42.9M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...